Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%

The Nifty Pharma index has crossed its near-term resistance at 13,700, and may spurt another 1.5 per cent.

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Web Exclusive Premium

Pharma stocks

Shares of pharmaceuticals companies were seen in demand on Monday, with the likes of Aurobindo Pharma and Glenmark surging 5 per cent and 4 per cent, respectively.

Also Read

Breakout on the cards? Tata Steel, Vedanta, SAIL can rise up to 12%

HDFC, Bajaj Finserv: Here's how to trade HDFC and Bajaj group stocks

Amara Raja, Minda: How to trade EV-related stocks ahead of Budget 2022?

NTPC, IRCTC, Coal India: How to trade PSU stocks ahead of Budget 2022?

Q3 earnings impact: Infy, TCS can rally up to 10%, Wipro may weaken further

Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug

Future Group shares hit record lows; Future Retail tanks 16% in two days

Accenture Q2FY22 results and what it means for the Indian IT sector

Greaves Cotton rises 6%; rallies 15% in two days on heavy volumes

IT shares gain on Accenture's strong Q2 show, higher revenue guidance

First Published: Mar 21 2022 | 12:44 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to